Short answer

Designers and manufacturers in the pharmaceutical sector should explore additive manufacturing techniques like continuous 3D printing to create more adaptable and patient-friendly drug delivery systems.

Field: Commercial Production
Source: Expert Opinion on Drug Delivery (2026)
Method: Experimental research and development
Evidence: Strong effect

Coupling hot melt extrusion with direct extrusion additive manufacturing allows for the continuous production of customized pediatric gummy medications with controlled drug release and enhanced palatability. This commercial production research insight is drawn from a 2026 study published in Expert Opinion on Drug Delivery. Using Experimental research and development, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers and manufacturers in the pharmaceutical sector should explore additive manufacturing techniques like continuous 3D printing to create more adaptable and patient-friendly drug delivery systems.

Study

Commercial ProductionNew This WeekStrong effect

Continuous 3D printing of pediatric gummies achieves 90% drug release in 30 minutes

Expert Opinion on Drug Delivery · 2026

Key Findings

01Tablet geometry, infill density, and ink composition can be adjusted to achieve immediate drug release.
0230% and 50% infill densities resulted in reduced compressive resistance suitable for chewable tablets.
03Optimized formulations achieved nearly 90% drug release within 30 minutes.
04Hydrogen-bonding interactions effectively masked taste, and optimized sweetener-flavor ratios ensured palatability.

Application

Design takeaway

How to apply

Consider using 3D printing to develop customized medications for specific patient needs, such as varying dosages, release profiles, or palatability for children or elderly patients.

Project actions

01Investigate how different infill densities affect the mechanical properties of 3D printed objects.
02Explore methods for taste masking in edible products.

Method & Evidence

AimTo develop and evaluate a continuous 3D printing platform for fabricating chewable pediatric gummy tablets with tailored drug release and sensory profiles.

MethodExperimental research and development

ProcedureA continuous 3D printing platform was created by integrating hot melt extrusion with direct extrusion additive manufacturing. Various tablet geometries, infill densities, and ink compositions were tested. Dissolution studies, mechanical compression tests, and sensory assessments were conducted to evaluate the fabricated gummies.

ContextPharmaceutical manufacturing, pediatric medicine

Variables

IV["Tablet geometry","Infill density","Ink composition"]

DV["Drug release rate","Compressive resistance","Taste (palatability)"]

CV["Type of drug","Base gummy material","Printing temperature and speed"]

Strengths & Limitations

Strengths

+Demonstrates a novel continuous manufacturing process.
+Addresses key challenges in pediatric medication adherence.
+Provides quantifiable data on drug release and mechanical properties.

Limitations

The complexity of integrating hot melt extrusion and direct extrusion might be challenging for smaller-scale design projects.

Reliability & validity

The study's reliability could be enhanced by repeating dissolution and mechanical tests multiple times. Validity is supported by the use of established methods for drug release and sensory assessment.

Think critically

How might the scalability and cost-effectiveness of this continuous 3D printing process compare to traditional pharmaceutical manufacturing methods for mass-produced medications?

Design Principles

"Leverage additive manufacturing to achieve multi-functional customization of pharmaceutical products."

This research demonstrates a novel manufacturing process that can lead to more patient-centric pharmaceutical products. By enabling customization of mechanical properties, dissolution rates, and taste, it addresses key challenges in pediatric medication adherence and efficacy.

What This Means for Your Design

This study shows how 3D printing can be used to make children's medicine more effective and easier to take by creating custom gummy candies that release medicine quickly and taste good.

How to use in your project

1.Use this research to justify the selection of additive manufacturing for a design project focused on customized products.
2.Cite this study when discussing the benefits of tailored drug delivery systems.

Add to My Project

Quick Cite

Paragraph starter

The continuous manufacturing approach demonstrated by Kolipaka et al. (2026) for pediatric gummy medications, which couples hot melt extrusion with direct extrusion additive manufacturing, offers a compelling precedent for designing customized pharmaceutical products. Their findings indicate that tailoring tablet geometry, infill density, and ink composition can precisely control drug release rates and mechanical properties, achieving nearly 90% drug release within 30 minutes and ensuring palatability through effective taste masking. This highlights the potential of additive manufacturing to enhance patient compliance and personalize treatment.

Source

Expert Opinion on Drug Delivery

Continuous manufacturing of 3D-printed chewable pediatric gummies by coupling hot melt extrusion with direct extrusion additive manufacturing

journal · 2026

View source

Questions About This Research

What does the research say about continuous 3d printing of pediatric gummies achieves 90% drug release in 30 minutes?: Designers and manufacturers in the pharmaceutical sector should explore additive manufacturing techniques like continuous 3D printing to create more adaptable and patient-friendly drug delivery systems. Evidence: Expert Opinion on Drug Delivery (2026).
Why does "Continuous 3D printing of pediatric gummies achieves 90% drug release in 30 minutes" matter for design?: This research demonstrates a novel manufacturing process that can lead to more patient-centric pharmaceutical products. By enabling customization of mechanical properties, dissolution rates, and taste, it addresses key challenges in pediatric medication adherence and efficacy.
How can designers apply this research?: Designers and manufacturers in the pharmaceutical sector should explore additive manufacturing techniques like continuous 3D printing to create more adaptable and patient-friendly drug delivery systems.
What were the main findings?: Tablet geometry, infill density, and ink composition can be adjusted to achieve immediate drug release.. 30% and 50% infill densities resulted in reduced compressive resistance suitable for chewable tablets.. Optimized formulations achieved nearly 90% drug release within 30 minutes.. Hydrogen-bonding interactions effectively masked taste, and optimized sweetener-flavor ratios ensured palatability.
What research method was used?: Experimental research and development.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2026 journal from Expert Opinion on Drug Delivery.
What should I do differently in my next project?: Consider using 3D printing to develop customized medications for specific patient needs, such as varying dosages, release profiles, or palatability for children or elderly patients.
What are the limitations?: The study focused on specific drug release profiles and did not explore long-term stability or a wide range of pediatric age groups.